JP2023539344A5 - - Google Patents

Info

Publication number
JP2023539344A5
JP2023539344A5 JP2023514081A JP2023514081A JP2023539344A5 JP 2023539344 A5 JP2023539344 A5 JP 2023539344A5 JP 2023514081 A JP2023514081 A JP 2023514081A JP 2023514081 A JP2023514081 A JP 2023514081A JP 2023539344 A5 JP2023539344 A5 JP 2023539344A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
contraceptive
levonorgestrel
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023514081A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023539344A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/048127 external-priority patent/WO2022051198A1/en
Publication of JP2023539344A publication Critical patent/JP2023539344A/ja
Publication of JP2023539344A5 publication Critical patent/JP2023539344A5/ja
Pending legal-status Critical Current

Links

JP2023514081A 2020-09-01 2021-08-30 カボテグラビルおよびレボノルゲストレルの組合せ Pending JP2023539344A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063073140P 2020-09-01 2020-09-01
US63/073,140 2020-09-01
PCT/US2021/048127 WO2022051198A1 (en) 2020-09-01 2021-08-30 Combination of cabotegravir and levonorgestrel

Publications (2)

Publication Number Publication Date
JP2023539344A JP2023539344A (ja) 2023-09-13
JP2023539344A5 true JP2023539344A5 (https=) 2024-09-06

Family

ID=77897768

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023514081A Pending JP2023539344A (ja) 2020-09-01 2021-08-30 カボテグラビルおよびレボノルゲストレルの組合せ

Country Status (4)

Country Link
US (1) US20230321089A1 (https=)
EP (1) EP4208169A1 (https=)
JP (1) JP2023539344A (https=)
WO (1) WO2022051198A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024353051A1 (en) * 2023-09-27 2026-03-12 ViiV Healthcare UK (No.3) Limited Pharmaceutical compositions
AU2023466962A1 (en) * 2023-09-27 2026-03-12 ViiV Healthcare UK (No.3) Limited Pharmaceutical composition of cabotegravir

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101363875B1 (ko) 2005-04-28 2014-02-21 시오노기세야쿠 가부시키가이샤 Ｈｉｖ 통합효소 억제 활성을 가지는 다환식카르바모일피리돈 유도체
TWI577377B (zh) * 2010-09-16 2017-04-11 Ｖｉｉｖ醫療保健公司 醫藥組合物
JP7703538B2 (ja) 2019-12-09 2025-07-07 ヴィーブ、ヘルスケア、カンパニー カボテグラビルを含んでなる医薬組成物

Similar Documents

Publication Publication Date Title
US10159681B2 (en) Method for on-demand contraception
JP2008505909A5 (https=)
US9827315B2 (en) Compositions of pharmaceutical actives containing diethylene glycol monoethyl ether or other alkyl derivatives
ES2704999T3 (es) Tratamiento de hemorragia por disrupción en regímenes anticonceptivos hormonales prolongados
TW200529862A (en) Extended use combination comprising estrogens and progestins
JP2010508275A5 (https=)
RU2009120528A (ru) Способы гормональной терапии возрастающими дозами в режиме пролонгированного цикла
JPH04290830A (ja) 避妊薬処方物
ZA200106006B (en) Triphasic oral contraceptive.
BR112012033391B1 (pt) Kit contraceptivo, e composição farmacêutica compreendendo drospirenona
JP2010532372A5 (https=)
JP2000514785A (ja) プロゲストゲン―抗プロゲストゲン処方
JP2023539344A5 (https=)
CN1062465A (zh) 仅用孕激素避孕
CN101511336A (zh) 口服单相避孕药的新给药方案
TWI351960B (en) Multiphase product for contraception based on a na
ES2959603T3 (es) Envase farmacéutico para terapia con estriol para el tratamiento de la esclerosis múltiple
US20230321089A1 (en) Combination of cabotegravir and levonorgestrel
JP2001523639A (ja) プロゲストゲン−抗プロゲストゲンレジメン
AU2019365204B2 (en) Pharmaceutical compositions and methods of making on demand solid dosage formulations
US8426392B2 (en) Method for providing emergency contraception
ES2777886T3 (es) Composición farmacéutica que comprende drospirenona y kit anticonceptivo
BR122025016695A2 (pt) Usos de drospirenona, composição farmacêutica e kit de drospirenona
HK40108056A (zh) 纯孕激素口服避孕
Crook The currently contraceptives oestrogen used component steroidal of